PATENT CLAIM ANALYSIS

Application Number: 15745625
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "172100"]

Abstract:
The presently disclosed subject matter relates to methods of improving insulin sensitivity in cells, tissues, and subjects, as well as methods of reducing insulin resistance, improving glucose homeostasis, reducing hepatic tryglyceride levels, reducing food intake, and treating metabolic disorders, such as those occurring in individuals who are obese, diabetic, and/or have hepatic steatosis.

Claim (Index 2):
The method of  claim 1 , wherein the expression level and/or activity of CTRP5 is decreased in the cell, tissue, or subject.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 86.0
- Lexical Diversity: 1.45455
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14021825', '14778379', '13396320', '15544385', '14389374']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7373940644268218
- 35 USC 102 Novelty (BERT): 0.5428994876131293
- Combined Prediction Score: 0.7179446067454525
- Mean Citation Score: 358.738126
- Max Citation Score: 377.97623
- Similarity Product: 211.4360138477361

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test